Antidepressant shows promise for sickle cell disease

02/20/2013 | MedicalDaily.com

The antidepressant tranylcypromine was able to stop a mechanism that leads to the development of sickle cell disease in laboratory tests, according to a study in the journal Nature Genetics. The drug allowed the production of fetal hemoglobin in tests of human cells and animals, researchers said.

View Full Article in:

MedicalDaily.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT